Crossmark

Advances in Physiologically Based Pharmacokinetic (PBPK) Modeling and its Regulatory Utility to Support Oral Drug Product Development and Harmonization

Crossref DOI link: https://doi.org/10.1007/s11095-025-03849-9

Published Online: 2025-03-28

Published Print: 2025-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Cheng, Yi-Hsien

Thomas, Sherin

Tsang, Yu Chung

Almeida, Susana

Ashraf, Muhammad

Fotaki, Nikoletta

Heimbach, Tycho

Patel, Nikunjkumar

Shah, Harshil

Jiang, Xiaojian

Kim, Myong-Jin

Moody, Rebecca

Rostami‐Hodjegan, Amin

Singh, Romi

Zhao, Liang

Babiskin, Andrew

Wu, Fang https://orcid.org/0009-0009-1485-8386
License Information

Text and Data Mining valid from 2025-03-28

Version of Record valid from 2025-03-28
More Information

Article History

Received: 15 December 2024

Accepted: 12 March 2025

First Online: 28 March 2025

Declarations

:

: The views expressed in this article are those of the authors and should not be construed to represent the FDA’s views or policies. The mention of commercial products, their sources, or their use in connection with material reported herein is not to be construed as either an actual or implied endorsement of such products by the FDA.

: The authors have no conflicts of interest to declare.

Document is current

Any future updates will be listed below